Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 376 to 400
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2020
-
PublicationsThe Health Products Regulation Group has published a new regulatory science strategy
-
PublicationsOur plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
-
Scheduling decisions (final)Final decision in relation to risankizumab
-
Scheduling decisions (final)Recommendations for the scheduling of New Chemical Entities for inclusion in the Poisons Standard
-
TGA laboratory testing reportsThe TGA Laboratories has published a detailed report related to the testing of measles vaccines available in Australia
-
PublicationsThe TGA has finalised the outcomes of the Lower Risk Registered OTC Products Review Pilot Project
-
PublicationsTGA instructions for disinfectant testing.
-
PublicationsTargets have been met for most measures under the six KPIs
-
PublicationsRegulatory Impact Self-Assessment Report
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 26 July 2019
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 27 November 2019
-
PublicationsOn Monday, 2 December 2019, a TGA Progress Report to the Senate Mesh Inquiry was tabled in the Senate
-
PublicationsThe TGA has conducted a safety review on coumarin in topical listed medicines
-
PublicationsThe TGA thanks respondents who provided a submission in response to the public consultation paper
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (final)Delegate-only final decision and reason for New Chemical Entities (NCE) - 1 December 2019 implementation date
-
Scheduling decisions (final)Final decisions to amend the Poisons Standard for substances referred to ACMS #27, ACCS #25, Joint ACMS-ACCS #22 (June 2019) and delegate-only decisions.
-
PublicationsFurther comments received on the consultation
-
Meeting statementsCommunique from the fourth meeting of the TGACC
-
PublicationsSubmissions received: Regulation of software, including Software as a Medical Device (SaMD)
-
PublicationsThe TGA thanks respondents who provided a submission in response to the public consultation paper
-
PublicationsPublication of submissions to the public consultation paper Proposed changes to the classification of active implantable medical devices and their accessories
-
PublicationsOverview of therapeutic goods advertising complaints handling and compliance for the year 2018-19